Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 407

1.

Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease.

Park SK, Ko BM, Goong HJ, Seo JY, Lee SH, Baek HL, Lee MS, Park DI.

World J Gastroenterol. 2017 May 21;23(19):3530-3537. doi: 10.3748/wjg.v23.i19.3530.

2.

Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans.

Viennois E, Zhao Y, Han MK, Xiao B, Zhang M, Prasad M, Wang L, Merlin D.

Sci Rep. 2017 May 31;7(1):2520. doi: 10.1038/s41598-017-02782-1.

3.

Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.

Heida A, Park KT, van Rheenen PF.

Inflamm Bowel Dis. 2017 Jun;23(6):894-902. doi: 10.1097/MIB.0000000000001082.

PMID:
28511198
4.

Discontinuation of Scheduled Infliximab in Crohn's Patients With Clinical Remission: A Retrospective Single-Center Study.

Hu H, Xiang C, Qiu C, Chen Z, Huang S, Liang L, Wang X.

Gastroenterology Res. 2017 Apr;10(2):92-99. doi: 10.14740/gr800w. Epub 2017 Apr 19.

5.

Transcriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn's Disease Patients.

Coope A, Pascoal LB, da Silva FAR, Botezelli JD, Ayrizono MLS, Milanski M, Camargo MG, Planell N, Portovedo M, Dias CB, Fagundes JJ, Leal RF.

Int J Inflam. 2017;2017:7646859. doi: 10.1155/2017/7646859. Epub 2017 Apr 9.

6.

Pulmonary dysfunction in 114 patients with inflammatory bowel disease.

Zhao Y, Wang J, Liu Z, Lin H, Shi Y, Sun X.

Medicine (Baltimore). 2017 May;96(18):e6808. doi: 10.1097/MD.0000000000006808.

7.

Intestinal Behçet and Crohn's disease: two sides of the same coin.

Valenti S, Gallizzi R, De Vivo D, Romano C.

Pediatr Rheumatol Online J. 2017 Apr 20;15(1):33. doi: 10.1186/s12969-017-0162-4. Review.

8.

Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype.

Wang ZZ, Shi K, Peng J.

Biomed Rep. 2017 Apr;6(4):401-410. doi: 10.3892/br.2017.860. Epub 2017 Feb 17.

9.

Vitamin D increases programmed death receptor-1 expression in Crohn's disease.

Bendix M, Greisen S, Dige A, Hvas CL, Bak N, Jørgensen SP, Dahlerup JF, Deleuran B, Agnholt J.

Oncotarget. 2017 Apr 11;8(15):24177-24186. doi: 10.18632/oncotarget.15489.

10.

Dynamic Contrast-Enhanced Magnetic Resonance Enterography and Dynamic Contrast-Enhanced Ultrasonography in Crohn's Disease: An Observational Comparison Study.

Wilkens R, Peters DA, Nielsen AH, Hovgaard VP, Glerup H, Krogh K.

Ultrasound Int Open. 2017 Feb;3(1):E13-E24. doi: 10.1055/s-0042-123841.

11.

Aseptic Abscesses and Inflammatory Bowel Disease: Two Cases and Review of Literature.

Bollegala N, Khan R, Scaffidi MA, Al-Mazroui A, Tessolini J, Showler A, Colak E, Grover SC.

Can J Gastroenterol Hepatol. 2017;2017:5124354. doi: 10.1155/2017/5124354. Epub 2017 Feb 6. Review.

12.

Second Korean guidelines for the management of Crohn's disease.

Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H; IBD Study Group of the Korean Association for the Study of Intestinal Diseases.

Intest Res. 2017 Jan;15(1):38-67. doi: 10.5217/ir.2017.15.1.38. Epub 2017 Jan 31. Review.

13.

α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.

Manolakis AC, Christodoulidis G, Kapsoritakis AN, Georgoulias P, Tiaka EK, Oikonomou K, Valotassiou VJ, Potamianos SP.

World J Gastroenterol. 2017 Jan 21;23(3):437-446. doi: 10.3748/wjg.v23.i3.437.

14.

Therapeutic efficacy of an elemental diet for patients with crohn's disease and its association with amino acid metabolism.

Nakano M, Tominaga K, Hoshino A, Sugaya T, Kanke K, Hiraishi H.

Saudi J Gastroenterol. 2017 Jan-Feb;23(1):20-27. doi: 10.4103/1319-3767.199110.

15.

Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn's disease.

Łykowska-Szuber L, Klimczak K, Eder P, Krela-Kaźmierczak I, Stawczyk-Eder K, Michalak M, Studniarek A, Kościński T, Szymczak A, Linke K.

Prz Gastroenterol. 2016;11(4):232-238. doi: 10.5114/pg.2015.55700. Epub 2015 Nov 23.

16.

Crohn's disease Activity: Abdominal Computed Tomography Histopathology Correlation.

Paquet N, Glickman JN, Erturk SM, Ros PR, Heverhagen JT, Patak MA.

Eur J Radiol Open. 2016 Apr 11;3:74-78. eCollection 2016.

17.

High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.

Bodelier AG, Jonkers D, van den Heuvel T, de Boer E, Hameeteman W, Masclee AA, Pierik MJ.

Dig Dis Sci. 2017 Feb;62(2):465-472. doi: 10.1007/s10620-016-4397-6. Epub 2016 Dec 8.

18.

Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn's disease.

Zhang M, Hong L, Zhang T, Lin Y, Zheng S, Zhou X, Fan R, Wang Z, Zhang C, Zhong J.

Patient Prefer Adherence. 2016 Nov 23;10:2387-2396. eCollection 2016.

19.

Care of inflammatory bowel disease patients in remission.

Raghu Subramanian C, Triadafilopoulos G.

Gastroenterol Rep (Oxf). 2016 Nov;4(4):261-271. Epub 2016 Oct 10. Review.

20.

Value of Computerized Tomography Enterography in Predicting Crohn's Disease Activity: Correlation with Crohn's Disease Activity Index and C-Reactive Protein.

Park EK, Han NY, Park BJ, Sung DJ, Cho SB, Jeen YT, Keum B, Kim MJ.

Iran J Radiol. 2016 Jun 21;13(4):e34301. eCollection 2016 Oct.

Supplemental Content

Support Center